Domenico Valerio
CIK: 0002117550
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
PRQR
ProQR Therapeutics N.V.
Director
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Valerio Domenico
Valerio Domenico (SEC CIK 0002117550) files insider reports with the SEC as Director of ProQR Therapeutics N.V. (PRQR).
Signal8 holds 1 ownership filing by Valerio Domenico, a Form 3, filed on Mar 18, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Valerio Domenico's filings is in LEIDEN.
Other insiders filing for ProQR Therapeutics N.V. (PRQR)
- de Boer Daniel Anton, Chief Executive Officer
- Filius Bart, Director
- Hinsch Gylvin Lykke, Director
- Platenburg Gerardus Johannes, Chief Scientific Officer
- Maier Martin Alexander, Director
- Lawton Alison Frances, Director